Inhibition and knockdown of PCK2 enhanced apoptosis and cell death under glucose deprivation in lung cancer cells with inactivating mutations of the tumor suppressor liver kinase B1 (LKB1), but not in a lung cancer cell line with wild-type LKB1 [4]. The gene discussed is PCK2; the disease is lung cancer.